Table 1.
Changes of different parameters of mice after 8 weeks of treatment of vehicle, STZ, STZ+valsartan (10 or 20 mg/kg), and valsartan (20 mg/kg)
| Treatment | Number of animals | Body weight (g) | Plasma glucose (mg/dl) | Plasma insulin (ng/ml) | Plasma tissue factor activity (pM) |
|---|---|---|---|---|---|
| Vehicle | 7 | 29.6 ± 2.4 | 149.3 ± 13.9 | 0.88 ± 0.24 | 7.3 ± 0.9 |
| STZ | 10 | 23.8 ± 1.2** | 336.3 ± 54.5** | 0.13 ± 0.02** | 11.0 ± 1.4** |
| STZ+Valsartan (10 mg/kg) | 10 | 23.9 ± 1.2 | 298.2 ± 88.1 | 0.17 ± 0.10 | 11.1 ± 2.5 |
| STZ+Valsartan (20 mg/kg) | 10 | 24.2 ± 1.2 | 210.1 ± 61.4†† | 0.49 ± 0.10†† | 9.2 ± 1.6† |
| Valsartan (20 mg/kg) | 7 | 27.7 ± 1.2 | 145.4 ± 35.7 | 0.68 ± 0.13 | 9.0 ± 1.1 |
Value are means ± SEM.
**P < 0.01 versus Vehicle.
†P < 0.05,
††P < 0.01 versus STZ, respectively.